πŸ‡ΊπŸ‡Έ FDA
Patent

US 10308605

Proton pump inhibitors

granted A61KA61K31/4025A61K31/41

Quick answer

US patent 10308605 (Proton pump inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/4025, A61K31/41, A61K31/4439, A61K31/501